FREDERICK, Md.--(BUSINESS WIRE)--BioElectronics Corp. (Pink Sheets:BIEL), the maker of ActiPatch™, the drug-free, anti-inflammatory patch, with an embedded, battery-operated microchip delivering continuous pulse therapy that revolutionizes the way people heal, today announced results from an important clinical study designed to determine the benefits of pulsed electromagnetic therapy using ActiPatch topical patch devices. Significantly positive results were achieved, clearly demonstrating the efficacy and safety of this simple, low-cost method to reduce pain within the first few days after breast augmentation.
